Metraipolis › archive › dc_dff4a7b8409e
Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40429476
- DOI
- 10.3390/jcm14103481
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T16:34:42.584Z
- SHA-256 of the archived text
f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460- Stable URL of this page
https://metraipolis.com/documento/dc_dff4a7b8409e
How to cite
Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476 — Europe PMC (en), https://europepmc.org/article/MED/40429476 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dff4a7b8409e (Metraipolis archive dc_dff4a7b8409e, sha256 f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460)
BibTeX
@misc{dcdff4a7b8409e,
title = {Pharmacological Management of Transthyretin Amyloid Cardiomyopathy: Where We Are and Where We Are Going — Europe PMC PMID:40429476},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40429476},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dff4a7b8409e; sha256 f1d687c045ee071d514758dfbc07ab68d3fa7a0243862017fdcfdb6a4f57c460},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40429476. Agents can read the archived copy with the MCP tool read_document.